Skip to content

Chronic Intradialytic Exercise : a Cardioprotective Role

Chronic Intradialytic Exercise: a Cardioprotective Role

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04697459
Acronym
EX-CHRODIAL
Enrollment
61
Registered
2021-01-06
Start date
2020-12-13
Completion date
2023-09-30
Last updated
2023-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Renal Failure

Keywords

exercise, hemodialysis

Brief summary

The main objective is to assess the effects of chronic intradialytic physical exercise on myocardial remodelling and regional function.

Detailed description

Background: Hemodialysis patients have a mortality rate 50 times higher than in the general population, and the cause remains cardiovascular in more than half of the cases. A deleterious morphological and functional cardiac remodelling is well established in these patients, the causes of which are both the presence of factors specific to renal disease (hemodynamic and non-hemodynamic) and co-morbidities (diabetes, hypertension, etc. .) but also to the hemodialysis (HD) procedure itself, due to the sudden hemodynamic changes it imposes, leading to repeated episodes of intradialytic hypotension (HID) and myocardial stunning. The latter are now documented as direct contributors to the increased mortality observed in HD patients compared to the general population. The introduction of intradialytic physical exercise in the therapeutic program of HD patient is now recommended and practised routinely in many countries, in Scandinavia in particular. Several meta-analyses have clearly established its safety. The beneficial role of chronic intradialytic exercise in improving dialysis efficiency, mental health and quality of life, as well as the inflammatory status of HD patients is also clearly demonstrated. Chronic intradialytic exercise is also associated with improvements in overall fitness level, a parameter closely linked to cardiovascular mortality. Applied acutely during dialysis, it could play a cardioprotective role (e.g; limiting myocardial stunning), allowing haemodynamic and cardiac functional stabilization during HD. However, to our knowledge, no study to date has investigated the long-term effects of intradialytic exercise on remodelling and overall and regional heart function. Aims: The main objective is to assess the effects of chronic intradialytic physical exercise on myocardial remodelling and regional function. The secondary objectives are to evaluate the effect of acute intradialytic exercise on myocardial stunning as well as the effect of chronic physical exercise on macro and microcirculatory vascular function, inflammation, physical fitness and health-related quality of life.

Interventions

OTHERchronic phase

1h of intradialytic execise, starting 30 min after hemodialysis beginning : 30 min of low-intensity (Borg Scale 11-14) aerobic exercise + 30 min of resistance training, frequency : 3 times a week for 16 weeks.

30 min of low-intensity (Borg Scale 11-14) aerobic exercise, starting 30 min after hemodialysis beginning

Sponsors

University of Avignon
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Intervention model description

* Acute phase : standard HD versus HD with acute intradialytic exercise (in HD-EX group only); * Chronic phase : before and after an exercise training program of 16 weeks (HD-EX group) as well as before and after 16 weeks of standard HD (HD group)

Eligibility

Sex/Gender
ALL
Age
20 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* No medical contraindication to physical activity * Life expectancy greater than 6 months * Patients on haemodialysis for more than 3 months

Exclusion criteria

* Pregnancy * Valvular heart disease, * Unstable coronary artery disease * Arteriopathy obliterating of the lower limbs stage III and IV * Musculoskeletal problems * Severe respiratory disease * BMI\> 35 * Pacemaker, cardiac stimulation and automatic implantable defibrillator * Heart transplant * Uncontrolled arterial hypertension * Ejection fraction \<45%

Design outcomes

Primary

MeasureTime frameDescription
Changes in myocardial longitudinal deformationsAcute phase : just before and 90 and 210 minutes within standard dialysis or dialysis including acute exercise.Myocardial longitudinal linear deformations (in percent) will be assessed by high-resolution echocardiography in deformation imaging mode.
Changes in myocardial circumferential deformationsAcute phase : just before and 90 and 210 minutes within standard dialysis or dialysis including acute exercise.Myocardial circumferential linear deformations (in percent) will be assessed by high-resolution echocardiography in deformation imaging mode.
Changes in left ventricular torsionAcute phase : just before and 90 and 210 minutes within standard dialysis or dialysis including acute exercise.Left ventricular torsion (in degree) will be assessed by high-resolution echocardiography in deformation imaging mode.

Secondary

MeasureTime frameDescription
Changes in arterial rigiditybefore (week 0) and after (week 17) an exercise training program of 16 weeksMeasurement of pulse wave velocity (m/s) by photo-plethysmography at rest before dialysis.
Changes in carotid intimal-media wall thicknessbefore (week 0) and after (week 17) an exercise training program of 16 weeksThe intimal plus media wall thickness (mm) of the right carotid artery will be measured using high-resolution echography.
Changes in Physical fitnessbefore (week 0) and after (week 17) an exercise training program of 16 weeksThe six-minute walking test (meters); maximal isometric force (newtons) during a knee-extension test and handgrip test using a dynamometer.
Health-related Quality of lifebefore (week 0) and after (week 17) an exercise training program of 16 weeksThe 36-Item Short Form Health Survey questionnaire. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026